Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.
With approximately 70% of American adults meeting the criteria for being obese or overweight, more people are turning to weight loss medications to help them shed pounds.
Ozempic is approved for type 2 diabetes, while its counterpart, Wegovy, is approved for treating obesity. Both are made by Novo Nordisk.
‘YO-YO’ WEIGHT LOSS OCCURS BECAUSE OF THIS SURPRISING REASON
Eli Lilly also offers a diabetes medication, Mounjaro, as well as a version for weight loss, Zepbound.
«Ozempic is the only version among the weekly injectables — Ozempic, Wegovy, Zepbound and Mounjaro — that has the option to ‘hack’ the pen for a smaller dose,» Dr. Alexandra Sowa, an obesity medicine specialist and founder of SoWell in New York, told Fox News Digital.
She is also the author of the book «The Ozempic Revolution» that is set to be released on Jan. 7.
Fox News Digital spoke to the experts to get th..